UCLA Health Jonsson Comprehensive Cancer Center

The UCLA Health Jonsson Comprehensive Cancer Center is a globally recognized leader in cancer research, prevention, treatment, clinical care, and survivorship. Among the first institutions to achieve National Cancer Institute comprehensive cancer center designation in 1976, the Center has maintained this prestigious designation continuously for nearly five decades. The Center’s mission is to accelerate discoveries that prevent and cure cancer through transformative science, multidisciplinary collaboration, and compassionate patient care. UCLA researchers and physicians have a long history of pioneering breakthroughs that have changed the practice of medicine and led to the development of transformative therapies, including Herceptin, Keytruda, Gleevec, Sprycel, Xtandi, Ibrance, and Yescarta. Bringing together leading experts across laboratory, translational, clinical, and population sciences, the Center is committed to advancing innovative therapies, expanding access to cutting-edge clinical trials, and improving cancer outcomes for diverse communities locally and globally.